10 Years of Letrozole Reduces Recurrence Risk With No Worsening in QOL

Article

Duration of aromatase inhibitor (AI) therapy for postmenopausal women with early stage breast cancer has been debated for some time.

Duration of aromatase inhibitor (AI) therapy for postmenopausal women with early stage breast cancer has been debated for some time. In addition, there have been questions about the impact of longer-duration (> 5 years) AI therapy on quality of life (QOL). Researchers from the Massachusetts General Hospital in Boston evaluated the risk of recurrence after 10 years of AI therapy and its effect on QOL in a randomized, open-label, phase III trial.

A total of 1918 postmenopausal women who had received 5 years of aromatase inhibitor therapy as either initial therapy or after prior tamoxifen were enrolled in the study. Women were randomly assigned to receive letrozole or a placebo. Patient-reported QOL was measured and women also completed a menopause-specific questionnaire.

At a median follow-up of 6.3 years, a 34% reduction in breast cancer recurrence was observed among the women taking letrozole when compared with women who had taken the placebo. A 58% reduction in contralateral breast cancer with letrozole also was observed, although there was no difference in overall survival between the women treated with letrozole or a placebo. There was also no worsening of quality of life in either group.

Goss PE, Ingle JN, Pritchard K, et al. A randomized trial (MA. 17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer. J Clin Oncol 2016;34(suppl; abstract LBA1).

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Photo of a woman with brown hair and bangs, surrounded by a blue border
Image of a woman with a white shirt in front of an Oncology Nursing News branded backdrop
Photo of a man with glasses in a suit in front of an Oncology Nursing News backdrop
Image of Jessie Desir, PhD, RN, AMB-BC, OCN, in a video call with a blue and gold Oncology Nursing News border surrounding the frame.
Image of a woman with glasses wearing a striped blouse and a black sweater in front of an Oncology Nursing News branded backdrop
Photo of Jamie Carroll, APRN, CNP, MSN, from a video call with an Oncology Nursing News branded border around the frame
Image of Kayle Freeman, DNP, APRN, FNP-C, in a video call with an Oncology Nursing News border around the frame